Skip to main content
. Author manuscript; available in PMC: 2018 May 1.
Published in final edited form as: Pharmacogenet Genomics. 2017 May;27(5):190–196. doi: 10.1097/FPC.0000000000000277

Table 2.

Distribution of CYP2C19 genotypes and metabolizer phenotypes

Genotype No. (%) Inferred phenotype No. (%)
*2/*2 1 (1.4) Poor Metabolizer* 1 (1.4)
*1/*2 13 (18.6) Intermediate Metabolizer* 14 (20)
*2/*17 1 (1.4)
*1/*1 28 (40) Normal Metabolizer 28 (40)
*1/*17 24 (34.3) Rapid Metabolizer 24 (34.3)
*17/*17 3 (4.3) Ultra-rapid Metabolizer 3 (4.3)

No patient had the *3 variant